• TREATMENT

    Trifluridine/tipiracil outcomes examined in patients 75 and older

    A single-center retrospective study compared relative dose intensity, toxicity, and survival between trifluridine/tipiracil (FTD/TPI) monotherapy and FTD/TPI plus bevacizumab in older patients with metastatic colorectal cancer, examining the relationship between dose intensity and overall survival. (Journal of Gastrointestinal Cancer)